LIPAC Oncology LLC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2016-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.lipaconcology.com
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer
Phase 1
Completed
- Conditions
- Bladder Cancer Cell TransitionalNon-Muscle Invasive Bladder CancerBladder CancerUrinary BladderTransitional Cell Carcinoma of the BladderUrinary Bladder NeoplasmsUrologic NeoplasmsUrogenital NeoplasmsUrinary Bladder DiseasesUrologic Diseases
- Interventions
- First Posted Date
- 2017-03-16
- Last Posted Date
- 2025-06-27
- Lead Sponsor
- Lipac Oncology LLC
- Target Recruit Count
- 15
- Registration Number
- NCT03081858
- Locations
- 🇺🇸
Urological Associates of Southern Arizona, PC, Tucson, Arizona, United States
🇺🇸Trovare Clinical Research, Bakersfield, California, United States
🇺🇸Tower Urology, Los Angeles, California, United States
News
No news found